NB-PP_1170x120

Issues

NACDS, NCPA applaud letter to Azar

NACDS, NCPA applaud letter to Azar

WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association (NCPA) have praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the secretary for concepts in the Centers for Medicare and Medicaid Services’ (CMS’) proposed rule, Modernizing Part D and Medicare Advantage to

DIR fee reform issues highlight NACDS Regional

DIR fee reform issues highlight NACDS Regional

PALM BEACH, Fla. — The National Association of Chain Drug Stores’ campaign-style approach to the issues crucial for pharmacy value and viability dominated this month’s opening session of the 2019 NACDS Regional Chain Conference. NACDS’ top-priority issue of direct and indirect remuneration (DIR) fee reform headlined the discussion of the association’s “Access Agenda” — which

Rite Aid stock split approved

Rite Aid stock split approved

CAMP HILL, Pa. — Last month Rite Aid Corp. announced that its board of directors has approved a reverse stock split of the company’s common stock. The reverse stock split is intended to enable Rite Aid to regain full compliance with the New York Stock Exchange listing rules. The split is subject to stockholder approval.

NACDS campaigns to make things happen

NACDS campaigns to make things happen

The National Association of Chain Drug Stores was at the top of its game during the Regional Chain Conference in Palm Beach, Fla., earlier this month. Often overshadowed by the association’s larger events, this hidden gem provides attendees with an initial look at the objectives that NACDS and its members will pursue during the course

NACDS RxIMPACT Day on Capitol Hill will keep DIR fee reform front-and-center

NACDS RxIMPACT Day on Capitol Hill will keep DIR fee reform front-and-center

ARLINGTON, Va. — In just over two weeks, pharmacy advocates from all 50 states will travel to Washington, D.C. for NACDS RxIMPACT Day on Capitol Hill. With direct and indirect remuneration (DIR) fee reform headlining the agenda, this event will make a powerful statement to the Trump Administration and to Congress about the crucial need

Hy-Vee adopts new opioid policy

Hy-Vee adopts new opioid policy

WEST DES MOINES, Iowa — To assist in combatting the national opioid epidemic, Hy-Vee Inc. has implemented a new controlled substance prescription policy. Since January 1, Hy-Vee pharmacies have not allowed a subsequent fill of a Schedule II controlled substance, or a refill of a Schedule III or Scheduled IV controlled substance more than 72

Wider role for CVS’ Sansone

Wider role for CVS’ Sansone

WOONSOCKET, R.I. — CVS Pharmacy has expanded the responsibilities of Judy Sansone, the chain’s senior vice president of front-store business and chief merchant. In addition, George Coleman has been promoted to senior vice president of merchandising, reporting to Sansone. He had been vice president of merchandising for consumer health care. Sansone’s team will be responsible

WBA joins Microsoft in health care partnership

WBA joins Microsoft in health care partnership

DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and Microsoft Corp. have teamed up to develop new health care delivery models, technology and retail innovations to advance and improve the future of health care. The companies will combine the power of Microsoft Azure, Microsoft’s cloud and artificial intelligence platform, health care investments, and new retail solutions

Case for DIR reform advanced

Case for DIR reform advanced

ARLINGTON, Va. — The National Association of Chain Drug Stores has submitted extensive and thoroughly documented comments to the Centers for Medicare and Medicaid Services (CMS) in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees — reform that relates directly to reducing patients’ out-of-pocket drug costs. NACDS issued its comments

1 2 3 207